GATTI, ALESSIO
 Distribuzione geografica
Continente #
EU - Europa 78
NA - Nord America 64
AS - Asia 29
SA - Sud America 14
AF - Africa 4
Totale 189
Nazione #
US - Stati Uniti d'America 63
IT - Italia 29
SG - Singapore 19
DE - Germania 14
BR - Brasile 12
FI - Finlandia 8
NL - Olanda 7
GB - Regno Unito 5
ES - Italia 4
FR - Francia 4
CH - Svizzera 3
TR - Turchia 3
CN - Cina 2
DZ - Algeria 2
PH - Filippine 2
CA - Canada 1
DK - Danimarca 1
HK - Hong Kong 1
IE - Irlanda 1
IN - India 1
LI - Liechtenstein 1
MA - Marocco 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SE - Svezia 1
ZA - Sudafrica 1
Totale 189
Città #
Singapore 13
Chandler 10
Ashburn 6
Santa Clara 6
London 5
Rome 5
Turku 5
Chicago 4
Munich 4
Frankfurt am Main 3
Helsinki 3
São Paulo 3
Zurich 3
Amsterdam 2
Angeles City 2
Bursa 2
Campinas 2
Chaoyang 2
Fuenlabrada 2
Lawrence 2
Milan 2
Princeton 2
Asunción 1
Austin 1
Belo Horizonte 1
Brooklyn 1
Buffalo 1
Casablanca 1
Copenhagen 1
Covina 1
Des Moines 1
Galway 1
Haarlem 1
Hamburg 1
Hanover 1
Hong Kong 1
Ibiúna 1
Izmir 1
Johannesburg 1
Lauro de Freitas 1
Lima 1
Marília 1
Mohernando 1
Mossoró 1
Naples 1
Nuremberg 1
Paris 1
Pasadena 1
Pune 1
Riyadh 1
Rondonópolis 1
San Francisco 1
San Marcellino 1
Secaucus 1
Stockholm 1
Wilmington 1
Totale 122
Nome #
Erratum: Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 (Journal of Perinatal Medicine (2020) 48:9 (950-958) DOI: 10.1515/jpm-2020-0355) 98
Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 30
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 23
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study 16
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes 14
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care 14
Totale 195
Categoria #
all - tutte 1.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.709


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 0 0 4 2 1 1 2 2 0
2022/202338 4 4 0 3 3 1 0 4 5 5 4 5
2023/202426 5 2 1 3 7 4 1 2 0 0 0 1
2024/202595 5 0 2 2 23 15 3 2 7 1 15 20
2025/202624 16 8 0 0 0 0 0 0 0 0 0 0
Totale 195